Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours

G Yadegarfar; L Friend; Leigh Robert Jones; L M Plum; J Ardill; B Taal; G Larsson; K Jeziorski; D Kwekkeboom; J K Ramage; EORTC Quality of Life Group

doi:10.1038/bjc.2012.560

Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours

G Yadegarfar, L Friend, Leigh Robert Jones, L M Plum, J Ardill, B Taal, G Larsson, K Jeziorski, D Kwekkeboom, J K Ramage, EORTC Quality of Life Group

94 Citations (Scopus)

Abstract

Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours.

Original language	English
Journal	B J C
Volume	108
Issue number	2
Pages (from-to)	301-10
Number of pages	10
ISSN	0007-0920
DOIs	https://doi.org/10.1038/bjc.2012.560
Publication status	Published - 5 Feb 2013

Keywords

Adult
Aged
Aged, 80 and over
Data Collection
Female
Gastrointestinal Neoplasms
Health Status
Humans
Male
Middle Aged
Neuroendocrine Tumors
Neurosecretory Systems
Quality of Life
Questionnaires

Access to Document

10.1038/bjc.2012.560

Cite this

Yadegarfar, G., Friend, L., Jones, L. R., Plum, L. M., Ardill, J., Taal, B., Larsson, G., Jeziorski, K., Kwekkeboom, D., Ramage, J. K., & EORTC Quality of Life Group (2013). Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. B J C, 108(2), 301-10. https://doi.org/10.1038/bjc.2012.560

@article{3f23b89388cb4946ab970af5963647e6,

title = "Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours",

abstract = "Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours.",

keywords = "Adult, Aged, Aged, 80 and over, Data Collection, Female, Gastrointestinal Neoplasms, Health Status, Humans, Male, Middle Aged, Neuroendocrine Tumors, Neurosecretory Systems, Quality of Life, Questionnaires",

author = "G Yadegarfar and L Friend and Jones, {Leigh Robert} and Plum, {L M} and J Ardill and B Taal and G Larsson and K Jeziorski and D Kwekkeboom and Ramage, {J K} and {EORTC Quality of Life Group}",

year = "2013",

month = feb,

day = "5",

doi = "10.1038/bjc.2012.560",

language = "English",

volume = "108",

pages = "301--10",

journal = "B J C",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours

AU - Yadegarfar, G

AU - Friend, L

AU - Jones, Leigh Robert

AU - Plum, L M

AU - Ardill, J

AU - Taal, B

AU - Larsson, G

AU - Jeziorski, K

AU - Kwekkeboom, D

AU - Ramage, J K

AU - EORTC Quality of Life Group

PY - 2013/2/5

Y1 - 2013/2/5

N2 - Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours.

AB - Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Data Collection

KW - Female

KW - Gastrointestinal Neoplasms

KW - Health Status

KW - Humans

KW - Male

KW - Middle Aged

KW - Neuroendocrine Tumors

KW - Neurosecretory Systems

KW - Quality of Life

KW - Questionnaires

U2 - 10.1038/bjc.2012.560

DO - 10.1038/bjc.2012.560

M3 - Journal article

C2 - 23322194

SN - 0007-0920

VL - 108

SP - 301

EP - 310

JO - B J C

JF - B J C

IS - 2

ER -

Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours

Abstract

Keywords

Access to Document

Fingerprint

Cite this